Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Pedro Folegatti


Clinical Research Fellow

Vaccine Clinical Trials

I am a Clinical Research Fellow and DPhil candidate on the Influenza and Emerging Pathogens vaccine clinical development programmes at The Jenner Institute - University of Oxford

My research focuses on the use of the simian adenovirus vector ChAdOx1 as a platform technology for vaccine development against emerging pathogens.

I am an investigator and the lead clinician for the COVID-19, MERS-CoV, Chikungunya, Zika, and Rift Valley Fever vaccine clinical trials

I trained as an Infectious Diseases physician in Brazil and hold a Masters degree in Public Health from the London School of Hygiene and Tropical Medicine.